• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Study on cellular signal transduction of Neurofibromatosis Type 1 and Type 2 tumor suppressor gene products

Research Project

Project/Area Number 14571319
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Cerebral neurosurgery
Research InstitutionKumamoto University

Principal Investigator

ARAKI Norie  Kumamoto University, Graduate School of Medical Sciences, Tumor Genetics & Biology, Associate Professor, 大学院・医学薬学研究部, 講師 (80253722)

Co-Investigator(Kenkyū-buntansha) SAYA Hideyuki  Kumamoto University, Graduate School of Medical Sciences, Tumor Genetics & Biology, Professor, 大学院・医学薬学研究部, 教授 (80264282)
Project Period (FY) 2002 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥4,000,000 (Direct Cost: ¥4,000,000)
Fiscal Year 2003: ¥1,500,000 (Direct Cost: ¥1,500,000)
Fiscal Year 2002: ¥2,500,000 (Direct Cost: ¥2,500,000)
KeywordsNeurofibromatosis Type 1 / NF1 / Neurofibromin / Neurofibromatosis Type 2 / NF2 / Merlin / Proteomics / brain tumor / プロテミクス / 脳腫瘍 / 学習障害
Research Abstract

The neurofibromatosis type 1 (NF1) and type 2 (NF2) are autosomal dominantly inherited disorders, and strongly associated with development of intracranial tumors including bilateral vestibular schwannomas, meningiomas and gliomas. NF1 and NF2 genes were recently identified on the different locus, and the proteins they encode (termed as neurofibromin for NF1 and merlin for NF2) were found to be no homologies despite of their pathological similarity. To elucidate the biological function of NF1 and NF2 proteins, we analyzed their signal transductions by cellular proteomic and biological strategies. 1)NF1 : Neurofibromin has a domain acting as a GAP and thought to be an important Ras regulator. We identified 35 novel cellular neurofibromin-associating proteins. 14-3-3 was identified as one of the most interesting core candidates of NF1 regulators. The interaction of 14-3-3 is mainly directed to the C-terminal domain (CTD) of neurofibromin, and the cAMP-dependent protein kinase (PKA)-depend … More ent phosphorylation clustered on CTD-Ser (2576, 2578, 2580, 2813) and Thr (2556) is required for the interaction. Interestingly, the increased phosphorylation and association of 14-3-3 negatively regulate the GAP activity of neurofibromin. These findings indicate that PKA phosphorylation followed by 14-3-3 protein and other protein cluster interactions may modulate the biochemical and biological functions of cellular neurofibromin. 2)NF2 ; Cellular binding proteins of merlin were identified as poly ADP-ribose polymerase, DNA-PK subunits Ku-antigen 85 and 70 by MAS spec analysis. The N-terminal (19-339) region of merlin is essential for their interaction. Subcellular co-localizations of merlin and PARP were observed mainly in their nuclear region with a nuclear export signal (NES) dependent manner of merlin. This nuclear accumulation increased with cellular DNA damages, whereas PARP gene deficient MEF could not accumulate merlin in their nuclear region, even after the treatments of LMB or bleomycin, These results suggest that merlin is a cytoplasmic-nuclear shuttling protein directed by its NES-dependent transport pathway being associated with PARP. The tumor suppressive function of merlin may be linked to cellular DNA-repair and related signals via the interaction of cellular merlin binding proteins such as PARP and DNA-PKs. Less

Report

(3 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • Research Products

    (34 results)

All Other

All Publications (34 results)

  • [Publications] Morisaki, T. et al.: "WARTS tumor suppressor is phosphorylated by Cdc2/cyclin B at spindle poles during mitosis."FEBS Letters. 529(2-3). 319-324 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Ochi, H. et al.: "Proteomic analysis of human brain identifies alpha-enolase as a novel autoantigen in Hashimoto's encephalopathy."FEBS Lett.. 528(1-3). 197-202 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 荒木 令江: "脳疾患の発現プロテオミクス解析,"細胞機能解析に向かうプロテオミクス""実験医学. 20(1). 13-22 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 荒木 令江: "癌の病態プロテオミクス"プロテオミクス医療への応用の可能性""医学のあゆみ. 202(5). 335-342 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 荒木 令江: "脳神経系変性疾患および神経系腫瘍の病態プロテオミクス"プロテオミクス-方法とその病態解析への応用""現代化学増刊. 42. 102-112 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Yunoue S. et al.: "Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GAP function toward Ras."J Biol Chem. 278(29). 26958-26969 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Watabe K. et al.: "Tissue culture methods to study neurological disorders : Establishment of immortalized Schwann cells from murine disease models."Neuropathology. 23(1). 68-78 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Feng L.et al.: "PKA phosphorylation and 14-3-3 interaction regulate GAP activity of the Neurofibromatosis Type I tumor suppressor, neurofibromin."FEBS letters. 557(1-3). 275-282 (2004)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Araki N. et al.: "Analysis of disease on the central nervous system by proteomic approaches"J.Electrophoresis. 47. 7-16 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 荒木令江: "脳神経系腫瘍および変性疾患の病態プロテオミクス"臨床医学増刊号. 47(11). 1373-1385 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 荒木令江: "「in vitroラベル法」オンラインLC-MS法による発現プロファイル解析"決定版!プロテオーム解析マニュアル""実験医学別冊. 111-124 (2004)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 荒木 令江: "脳疾患の病態プロテオミクス"注目のプロテオミクスの全貌を知る!"(磯辺俊明、高橋信弘編)"羊土社. 152-164 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Araki N. et al.: "Functional proteomic analysis of tumor supperssor related proteins in neuronal cells. "New aspects in Kidney disease""Arakawa M, Niigata Symposium of Nephrology Organizing Committee. 63-79 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Ochi H, Horiuchi I, Araki N^*, Toda T, Araki T, Sato K, Murai H, Osoegawa M, Yamada T, Okamura K, Ogino T, Mizumoto K, Yamashita H, Saya H, Kira J.: "Proteomic analysis of human brain identifies -enolase as a novel autoantigen in Hashimoto's encephalopathy."FEBS Letters. 528(1-3). 197-202 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Morisaki T, Hirota T, Iida S, Marumoto T, Hara T, Nishiyama Y, Kawasuzi M, Hiraoka T, Mimori T, Araki N, Izawa I, Inagaki M, Saya H.: "WARTS tumor suppressor is phosphorylated by Cdc2/cyclin B at spindle poles during mitosis"FEBS Letters. 529(2-3). 319 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Watabe K, Sakamoto T, Kawazoe Y, Michikawa M, Miyamoto K, Yamamura T, Saya H, Araki N: "Tissue culture methods to study neurological disorders : Establishment of immortalized Schwann cells from murine disease models."Neuropathology. 23(1). 68-78 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Yunoue S, Tokuo H, Fukunaga K, Feng L, Ozawa T, Nishi T, Kikuchi A, Hattori A, Kuratsu J, Saya H, Araki N^*: "Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GAP function toward Ras."J.Biol.Chem.. 278(29). 26958-26969 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Araki N, Kawano K, Toda T, Araki T, Tsugita A, Kira J, Saya H.: "Analysis of disease on the central nervous system by proteomic approaches."J.Electrophoresis. 47. 7-16 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Feng L, Yunoue S, Tokuo H, Ozawa T, Zhang D, Patrakitkomjorn S, Ichimura T, Saya H, Araki N.: "PKA phosphorylation and 14-3-3 interaction regulate the function of neurofibromatosis type I tumor suppressor, neurofibromin."FEBS Lett.. 557(1-3). 275-282 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Araki N, Yunoue S, Feng L, Ozawa T, Patrakitkomjorn S, Tsugita A, Saya H.: "Functional proteomic analysis of tumor supperssor related proteins in neuronal cells. New aspects in Kidney disease (Edited by Arakawa M)"Niigata Symposium of Nephrology Organizing Committee. 63-79 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Yunoue S.et al.: "Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GAP function toward Ras"J Biol Chem. 278(29). 26958-26969 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Watabe K.et al.: "Tissue culture methods to study neurological disorders : Establishment of immortalized Schwann cells from murine disease models"Neuropathology. 23(1). 68-78 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Feng L.et al.: "PKA phosphorylation and 14-3-3 interaction regulate GAP activity of the Neurofibromatosis Type I tumor suppressor, neurofibromin"FEBS letters. 557(1-3). 275-282 (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] Araki N.et al.: "Analysis of disease on the central nervous system by proteomic approaches"J.Electrophoresis. 47. 7-16 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] 荒木令江: "脳神経系腫瘍および変性疾患の病態プロテオミクス"臨床医学増刊号. 47(11). 1373-1385 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] 荒木令江: "「in vitroラベル法」オンラインLC-MS法による発現プロファイル解析"決定版!プロテオーム解析マニュアル""実験医学別冊. 111-124 (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] Araki N.et al.: "Functional proteomic analysis of tumor supperssor related proteins in neuronal cells. "New aspects in Kidney disease""Arakawa M, Niigata Symposium of Nephrology Organizing Committee. 63-79 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Yunoue, S. et al.: "Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GAP function toward Ras."J. Biol. Chem.. (In press). (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] Watabe, K., et al.: "Tissue culture methods to study neurological disorders : Establishment of immortalized Schwann cells from murine disease models"Neuropathology. (In press). (2003)

    • Related Report
      2002 Annual Research Report
  • [Publications] Maorisaki, T. et al.: "WARTS tumor suppressor is phosphorylated by Cdc2/cyclin B at spindle poles during mitosis"FEBS Letters. 529(2-3). 319-324 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Ochi, H. et al.: "Proteomic analysis of human brain identifies alpha-enolase as a novel autoantigen in Hashimoto's encephalopathy"FEBS Letters. 528(1-3). 197-202 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 荒木 令江: "脳疾患の発現プロテオミクス解析,"細胞機能解析に向かうプロテオミクス""実験医学. 20(1). 13-22 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 荒木 令江: "脳神経系変性疾患および神経系腫瘍の病態プロテオミクス"プロテオミクス-方法とその病態解析への応用""東京化学同仁. 102-112 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 荒木 令江: "脳疾患の病態プロテオミクス"注目のプロテオミクスの全貌を知る!""羊土社. 152-164 (2002)

    • Related Report
      2002 Annual Research Report

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi